Dr Gunjan Bhardwaj is the Founder and CEO of the Partex NV World's largest AI powered Drug Assets Manager – Solving the inefficiency problem of Life Sciences Industry in drug discovery & development using Big Data & Artificial Intelligence.

He is member of various AI Think tanks as well as a Not for Profit focused on Sustainability. He is also Founder of Innoplexus AG: an AI champion in the life science Industry.

He worked as an Adjunct professor at Pforzheim University, Germany.

He has led projects in strategy, analytics and technology for various clients in different parts of the world. Gunjan was also a partner, senior-editor and advisor for a prominent online innovation management journal and was a member of the scientific advisory board of a US based not for profit institute researching in complexity sciences in the healthcare industry.

He having 18+ patents related to AI & Blockchain, Published 2 books in Branding and Drug Discovery respectively as well as a number of publications in Harvard Business Review, Journal of Service Research, MIT Sloan Review etc. Gunjan’s work has been covered by various Newspapers, Business magazines and he has been a keynote speaker in various international event. He has 40 under 40 Award by Capital Magazine in Germany.

BCG-Handelsblatt young leader of future reality Award Top 30 most influential people of the new normal by Germany’s Focus Magazine. Excellent Leader with an Immigration Background Award by City of Frankfurt, Germany.